A Blood Test for Multiple Cancers Won a Key FDA Vote. Should You Get One?

Imagine being able to look for signs of several cancers with a single blood draw, including cancers for which we have no routine screening test. That is the promise behind multicancer detection tests, and it deserves our attention.

What the FDA Vote Actually Means

On September 23, 2026, an FDA advisory panel voted to approve Galleri for adults 50 and older. The vote was an important recommendation, but it was not final FDA approval. As of September 27, the agency was still reviewing the application.

Galleri is already available by prescription as a laboratory-developed test.

What Does Galleri Actually Look For?

The test looks for patterns in DNA fragments circulating in the blood. If it detects a cancer signal, it also predicts where in the body that signal may have originated.

A positive result is a starting point for a medical evaluation, not a cancer diagnosis. The FDA’s proposed indication specifically calls for a positive result to be followed by diagnostic evaluation by a qualified healthcare professional.

A Negative Result Does Not Mean “No Cancer”

What about a negative result? That is where expectations matter.

No blood test can promise that you do not have cancer. Galleri misses some cancers, particularly at early stages. The FDA specifically states that a “No Cancer Signal Detected” result does not rule out cancer.

It should be considered alongside, never in place of, recommended screening such as colonoscopy, mammography, or appropriate lung cancer screening. The FDA’s proposed indication explicitly says people should continue guideline-recommended single-cancer screening regardless of the Galleri result.

So, Should You Get the Test?

Would I dismiss the test? No. The possibility of finding a dangerous cancer before symptoms appear is significant.

Would I present it as a comprehensive cancer check or a substitute for established screening? Absolutely not.

For someone considering Galleri, I would ask three questions:

• Am I current on the screenings already recommended for me?
• What would we do if the result were positive?
• Would a negative result change anything I should still be doing?

New Technology Still Requires Clinical Judgment

The best use of a new test begins with an honest understanding of both its promise and its limits.

The question is not simply whether we can order a test. It is whether the information it provides is useful for you, how we will interpret the result, and what we will do next.

Let’s walk through each of those together. Schedule a 15-minute discussion with me today.